Gene · 5144
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets. | Chem Res Toxicol | 2023 | 37439496 | PubTator, text mining | PubMed |
| Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth. | JCI Insight | 2023 | 37427586 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell line generated from a patient with differences in sex development (DSD) and multiple genetic variants including a large deletion in NR5A1. | Stem Cell Res | 2023 | 37413951 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Approaches to COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37408603 | PubTator, text mining | PubMed |
| Behavioural deficits of autism spectrum disorder and associations with different gene clusters: a study with the whole-genome transmission disequilibrium test. | BMJ Paediatr Open | 2023 | 37407249 | PubTator, text mining | PubMed |
| The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer's disease and Parkinson's disease. | Front Physiol | 2023 | 37405135 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
| Difamilast for the treatment of atopic dermatitis. | J Int Med Res | 2023 | 37389929 | PubTator, text mining | PubMed |
| Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis. | BMC Gastroenterol | 2023 | 37370003 | PubTator, text mining | PubMed |
| PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. | Cell Death Dis | 2023 | 37355626 | PubTator, text mining | PubMed |
| Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC. | Front Endocrinol (Lausanne) | 2023 | 37347115 | PubTator, text mining | PubMed |
| Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals. | J Alzheimers Dis | 2023 | 37334609 | PubTator, text mining | PubMed |
| Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology. | Cell Mol Life Sci | 2023 | 37306762 | PubTator, text mining | PubMed |
| Proline hydroxylase 2 (PHD2) promotes brown adipose thermogenesis by enhancing the hydroxylation of UCP1. | Mol Metab | 2023 | 37279828 | PubTator, text mining | PubMed |
| Drug Discovery and Development Targeting Dementia. | Pharmaceuticals (Basel) | 2023 | 37259302 | PubTator, text mining | PubMed |
| Oxazolidinones as versatile scaffolds in medicinal chemistry. | RSC Med Chem | 2023 | 37252095 | PubTator, text mining | PubMed |
| Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer. | Front Immunol | 2023 | 37251402 | PubTator, text mining | PubMed |
| A Case of Hypoparathyroidism in Type 1 Diabetes Mellitus. | Cureus | 2023 | 37213970 | PubTator, text mining | PubMed |
| PDE4D/cAMP/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytes. | Cancer Lett | 2023 | 37196909 | PubTator, text mining | PubMed |
| Association of asthma genetic variants with asthma-associated traits reveals molecular pathways of eosinophilic asthma. | Clin Transl Allergy | 2023 | 37186423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5144/papers?page=13